| Bioactivity | HER2-targeted peptide H6F is a HER2 targeting peptide that binds to HER2 to target breast cancer cells, with the amino acid sequence YLFFVFER. The HER2-targeted peptide H6F can be conjugated with the bifunctional chelating agent hydrazinonicotinamide (HYNIC) for radiolabeling with 99mTc. Single-photon emission computed tomography (SPECT) imaging shows that the labeled HER2-targeted peptide H6F specifically accumulates in HER2-positive MDA-MBA-453 tumor-bearing mice models. The HER2-targeted peptide H6F can be used for tumor molecular imaging studies[1]. |
| CAS | 1644155-35-0 |
| Sequence | Tyr-Leu-Phe-Phe-Val-Phe-Glu-Arg |
| Shortening | YLFFVFER |
| Formula | C58H77N11O12 |
| Molar Mass | 1120.30 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Okarvi SM, et al. Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas. Molecules. 2019 Aug 29;24(17):3142. |
HER2-targeted peptide H6F
CAS: 1644155-35-0 F: C58H77N11O12 W: 1120.30
HER2-targeted peptide H6F is a HER2 targeting peptide that binds to HER2 to target breast cancer cells, with the amino a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.